Home

To assist with planning for COVID-19 we have analysed the following to identify numbers in at-risk cohorts based on extant international data for at-risk groups i.e. frailty, pre frailty; cardiovascular and chronic conditions; comorbidities; possible at- risk CVD and anti-inflammatory medications*; and living/household circumstances (social isolation) including grandparenting; community social care and health service utilisation.

The full report is available here.

To read more about Healthcare Utilisation and implications for COVID-19, click here.

To read more about Multimorbidity and implications for COVID-19, click here.

To read more about Frailty and implications for COVID-19, click here.

To read more about Vitamin D and implications for COVID-19, click here.

To read more about our adults aged over 70, click here.

Read our "Stay Home, Stay Safe" community supports leaflet here.

Notice March 12th 2020: Suspension of Wave 6 Activities

On foot of the instruction from Government for closure of schools, universities and other public services to delay the spread of COVID-19, TILDA is suspending its activities related to data collection for Wave 6 of the study. We will advise on when Wave 6 data collection is due to resume.

TILDA collects information on all aspects of health, economic and social circumstances from people aged 50 and over in a series of data collection waves once every two years. TILDA is unique amongst longitudinal studies in the breadth of physical, mental health and cognitive measures collected. This data, together with the extensive social and economic data, makes TILDA one of the most comprehensive research studies of its kind both in Europe and internationally.